500 kids with rare bleeding disorder to be tracked in landmark chinese study

NCT ID NCT06107582

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 500 children aged 6-17 diagnosed with immune thrombocytopenia (ITP), a rare autoimmune disease that causes low platelet counts and bleeding. Researchers will collect data on symptoms, treatments, and outcomes over several years to build a model that predicts how the disease will progress. No new treatments are being tested; the goal is to better understand the condition in Chinese children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC IMMUNE THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chinese Academy of Medical Science and Blood Disease Hospital

    RECRUITING

    Tianjin, 300020, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.